Trevena terminates royalty loan by assigning China license to R-Bridge; all debt discharged

TREVENA INC

Agreement dated Jan 9, 2026 with R-Bridge, Nhwa: royalty loan obligations released in exchange for China license rights (except milestones).
Trevena transfers all rights under China License Agreement to R-Bridge; Nhwa consents, future royalties (except milestones) paid to R-Bridge.
Loan Agreement and all security interests terminated; Trevena SPV1, SPV2, Royalty LLC released from obligations.
China License Agreement term extended to 10 years after first commercial sale (June 30, 2033), with possible renewal.
Trevena discontinued US commercialization of Olinvyk; covenants to enter new safety data exchange if resumed.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

TREVENA INC terminated License Agreement with Jiangsu Nhwa Pharmaceutical Co. Ltd. and R-Bridge Investment Four Pte. Ltd. (effective 2026-01-09).

Action: termination
Agreement: credit facility
Counterparty: Jiangsu Nhwa Pharmaceutical Co. Ltd. and R-Bridge Investment Four Pte. Ltd.
Effective: 2026-01-09

Exact text from the filing

On January 9, 2026, Trevena, Inc., Trevena SPV2 LLC, Trevena SPV1 LLC, and Trevena Royalty LLC (collectively the “Company”) entered into an Assignment and Release Agreement (the “Agreement) with Jiangsu Nhwa Pharmaceutical Co. Ltd. (“Nhwa”) and R-Bridge Investment Four Pte. Ltd., (the “Lender”) whereby the Lender agreed to terminate and release the Company from all obligations

View on SEC.gov

294 material agreements filed in the last 30 days. Browse all material agreements →

Source: SEC EDGAR

accession 0001104659-26-003726

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.